Clinical Trial Update: A Phase III Extended Clinical Trial of Jaktinib Hydrochloride Tablets in the Treatment of Moderate and Severe Atopic Dermatitis [Phase 3]

View source ↗

Summary

A Phase III extended clinical trial evaluating jaktinib hydrochloride tablets for moderate to severe atopic dermatitis is being conducted, with status not discl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Jaktinib hydrochloride tablets (Jaktinib hydrochloride)

Snippet

Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd | Conditions: Atopic Dermatitis | Phase 3 | Status: UNKNOWN